Increased Severity of Murine Infection with Toxioplasma Gondii Following Vitaman E and Selenium Supplementatoin by McCarthy, Susan
Western Kentucky University
TopSCHOLAR®
Masters Theses & Specialist Projects Graduate School
12-1-1999
Increased Severity of Murine Infection with
Toxioplasma Gondii Following Vitaman E and
Selenium Supplementatoin
Susan McCarthy
Western Kentucky University
Follow this and additional works at: http://digitalcommons.wku.edu/theses
Part of the Medical Sciences Commons
This Thesis is brought to you for free and open access by TopSCHOLAR®. It has been accepted for inclusion in Masters Theses & Specialist Projects by
an authorized administrator of TopSCHOLAR®. For more information, please contact topscholar@wku.edu.
Recommended Citation
McCarthy, Susan, "Increased Severity of Murine Infection with Toxioplasma Gondii Following Vitaman E and Selenium
Supplementatoin" (1999). Masters Theses & Specialist Projects. Paper 795.
http://digitalcommons.wku.edu/theses/795
INCREASED SEVERITY OF MURINE INFECTION WITH TOXOPLASMA 
GONDII FOLLOWING VITAMIN E AND SELENIUM SUPPLEMENTATION 
A Thesis 
Presented to the Faculty of the Department of Biology 
Western Kentucky University 
Bowling Green, Kentucky 
In Partial Fulfillment 
of the Requirements for the Degree 
Master of Science 
by 
Susan McCarthy 
December 1999 
INCREASED SEVERITY OF MURINE INFECTION WITH TOXOPLASMA 
GONDII FOLLOWING VITAMIN E AND SELENIUM SUPPLEMENTATION 
Date Recommended QM-KMsiJ tf 1 
Director of Thesis , > 
Director of Graduate Studies *j Date 
ACKNOWLEDGEMENTS 
I would like to extend a heartfelt thank you to Dr. Cheryl Davis for her continuous 
facilitation, support, and excellent direction throughout my entire thesis experience. Dr. 
Davis' mentorship and personal example always helped me strive and push myself to the 
next level. 
I would also like to thank Dr. Doug McElroy for his superb advice and assistance 
with my statistical analysis, and Dr. Sigrid Jacobshagen for her special attention and 
interest in my work. I truly appreciate Dr. John Andersland for his enormous help during 
my research. 
A special note of gratitude to Caroline (Flip) Nolen and her staff at Vanderbilt 
University for their assistance in the histological portion of my research. 
I would also like to thank the Graduate Student Research Committee for funding 
my research, and the entire faculty in the Department of Biology for their support. 
Last, I would like to thank my family, sister-in law, and best friend, Sherryl 
Lockett, for their encouragement, support and understanding during my research. 
111 
TABLE OF CONTENTS 
BACKGROUND 1 
Toxoplasma gondii 1 
Biology of the Parasite and Modes of Transmission 2 
Immunity and Pathogenesis 4 
The Effects of Antioxidants on Immune Function 7 
Vitamin E H 
Selenium 15 
The Combined Effect of Vitamin E and Selenium 19 
INTRODUCTION 24 
MATERIALS AND METHODS 29 
Mice 29 
Toxoplasma gondii Infection 29 
Experimental Design 30 
Weight 31 
Histological Evaluation 31 
Cyst Number Determination 32 
Statistical Evaluation 33 
RESULTS 34 
Effect of Diet on Weight 34 
Effect of Diet on Tissue Cyst Number 35 
Effect of Diet on Histopathology 36 
DISCUSSION 45 
iv 
LITERATURE CITED 
LIST OF TABLES 
TABLE PAGE 
1. Percent Weight Change 39 
2. Tissue Cyst Number 41 
3. Histopathology 42 
vi 
LIST OF FIGURES 
FIGURE PAGE 
1. Effect of Diet on Weight in T. gondii-lnfeclzd. Swiss Webster Mice 38 
2. Effect of Diet on Weight in T. g-oudii-Infected C57BL/6J Mice 40 
3. Histological Sections From Brains of Infected Swiss Webster Mice 43 
4. Histological Sections From Brains of Infected C57BL/6J Mice 44 
vii 
INCREASED SEVERITY OF MURINE INFECTION WITH TOXOPLASMA 
GONDII FOLLOWING VITAMIN E AND SELENIUM SUPPLEMENTATION 
Susan McCarthy December 1999 58 Pages 
Directed by: Cheryl D. Davis, Doug McElroy, and Sigrid Jacobshagen 
Department of Biology Western Kentucky University 
At present, toxoplasmosis is one of the most common opportunistic infections in 
immunocompromised patients. The need for a reliable experimental model is crucial not 
only for achieving a better understanding of the pathophysiology of this infection but also 
for developing a better method to evaluate new therapeutic regimens. This study was 
organized to determine if the antioxidants vitamin E and selenium would provide a 
beneficial effect in mice chronically infected with Toxoplasma gondii. In the first phase 
of the study, 35 female Swiss Webster mice were infected with oocysts of the Me49 
strain of Toxoplasma gondii while receiving diets supplemented with vitamin E alone or 
in combination with selenium, or a diet deficient in both nutrients. In the second phase of 
the study, 25 C57BL/6J mice were infected intraperitoneally (i.p) using the ME49 strain. 
Two different strains of mice were used for this experiment because each vary in their 
susceptibility to T. gondii infection, with the C57BL/6J mice being a more susceptible 
model with the development of toxoplasmic encephalitis. In the third phase of the study, 
because the natural route of infection is the oral route, 25 C57BL/6J mice were infected 
orally with the ME49 strain of Toxoplasma. The results of all three experiments 
demonstrate that vitamin E and Se supplementation does not provide a protective effect 
during murine Toxoplasma gondii infection. Mice fed diets supplemented with vitamin E 
and Se had more tissue cysts present in their brains, exhibited greater tissue pathology, 
viii 
and suffered the highest percent weight loss. In contrast, the unsupplemented groups 
(absence of vitamin E and Se from the diet) showed the lowest tissue cyst numbers, 
minor histopathology, and very little weight loss during experimental infection. 
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BACKGROUND 
Toxoplasma gondii 
Toxoplasma gondi is the protozoan parasite responsible for toxoplasmosis in 
humans and other warm-blooded animals (Bourguin et al., 1993). This parasite can infect 
most warm-blooded animals, both domestic and wild, and thus is among the most 
cosmopolitan of parasites (Plorde, 1990). Infections by T. gondii are widely prevalent in 
humans throughout the world; approximately one-half of the human population of the 
United States has been infected (Dubey et al., 1996). However, in the overwhelming 
majority of cases the infection is chronic, asymptomatic, and self-limiting. Although 
generally benign for healthy people, toxoplasmosis may cause abortion or neonatal 
malformations if contracted during,pregnancy. Furthermore, this disease is often lethal 
for immunocompromised patients such as those with AIDS, those with neoplastic 
disease, or bone marrow or heart transplant recipients (Bourguin et al., 1993). At least 
30% of patients with AIDS who have antibodies to T. gondii will develop toxoplasmic 
encephalitis (Suzuki and Joh, 1994). Toxoplasmic encephalitis has emerged as a major 
cause of morbidity and mortality in patients with acquired immunodeficiency syndrome 
(AIDS) and is the most common cause of brain lesions (Suzuki et al., 1994). In 
veterinary medicine, toxoplasmosis has great economic importance in many parts of the 
world due to abortion in cattle and neonatal loss. Sheep seem to be particularly 
susceptible, and Toxoplasma -caused abortions in this host often reach epidemic 
proportions (Roberts and Janovy, 1996). Thus, the importance of the organism as a 
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human and animal pathogen has stimulated a significant amount of research in recent 
years. 
Biology of the Parasite and Modes of Transmission 
Toxoplasma gondii is an intracellular parasite within many kinds of tissues, 
including muscle and intestinal epithelium. It may inhabit the nucleus of the host cell but 
usually lives in the cytoplasm (Roberts and Janovy, 1996). This invasive parasite enters 
host cells and multiplies within a highly modified vacuole, which does not acidify or fuse 
with the host lysosomal system (Shaw et al., 1998). Although susceptible to oxidative 
killing, T. gondii efficiently enters the host cell (ie., macrophages) without triggering the 
production of hydrogen peroxides (H2O2) or other toxic O2 metabolites. During and after 
entry, the parasite discharges its secretory organelles (rhopteries and dense granules), 
resulting in the accumulation of one or more parasite-derived proteins in the newly 
formed parasitophorous vacuole space (Joiner et al., 1990). 
Sexual reproduction of Toxoplasma gondii occurs only in the definitive host, the 
felines, and most importantly the domestic cat. When a cat is infected with T. gondii the 
parasites enter the cells lining the cat's small intestine and undergo rapid asexual 
reproduction (Plorde, 1990). The parasites enter the epithelial cells of the ileum, and 
once inside an epithelial cell, the parasite becomes a trophozoite that grows and prepares 
for merogony. With cell rupture, merozoites are released. The merozoites infect adjacent 
epithelial cells and repeat another asexual cycle or eventually differentiate into 
gametocytes, initiating sexual reproduction (Plorde, 1990). Fusion of the mature male 
and female gametocytes leads to the formation of an oval, thick- walled oocyst that is 
passed in the feces. Oocysts appear in the cat's feces from 3 to 5 days after infection 
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with T. gondii, and in a typical infection millions of oocysts are released daily for 1-3 
weeks (Roberts and Janovy, 1996). The asexual stage disappears from the cat's small 
intestine after 3 weeks and so the cat stops producing oocysts. The oocysts are immature 
at the time of shedding and require oxygen for sporulation; they sporulate in 1 to 5 days 
(Roberts and Janovy, 1996). Upon maturation, 2 sporocysts (each containing 4 
sporozoites) develop within each oocyst (approximately 10-12 |j.m). Once mature, the 
resistant oocyst may remain infectious for as long as a year (Plorde, 1990). 
Asexual reproduction occurs only in the intermediate host (humans, domestic and 
wild animals). Intermediate hosts become infected by ingesting oocysts via infected cat 
feces or by eating raw or undercooked meat that contains tissue cysts. When the 
intermediate host swallows mature oocysts, digestive enzymes in the gastrointestinal tract 
disrupt the cyst wall (Plorde, 1990). Sporozoites are released from the disrupted cyst and 
are distributed to all parts of the body. They enter various kinds of cells, such as striated 
muscles and retinal cells, but ultimately the parasite tends to localize in the central 
nervous system (Roberts and Janovy, 1996). Following rapid asexual proliferation, the 
host cells rupture and liberate trophozoites known as tachyzoites. The tachyzoites are 
small banana-shaped crescents that measure 4-7 |im long and that must enter new host 
cells to initiate another asexual cycle (Bogitsh and Chang, 1990). As the number of 
tachyzoites increases due to repeated cycles of proliferation, the host reacts by producing 
specific antibodies that curtail proliferation (Dailey, 1996). When this stage is reached, 
the infection passes into a chronic stage characterized by the formation of intracellular 
cysts packed with numerous trophozoites designated as bradyzoites. (Dailey, 1996). The 
cysts become surrounded by a tough wall and are called tissue cysts. Eventually, tissue 
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cysts measure up to 200 |am in diameter and may contain more than a thousand 
bradyzoites. Cysts remain in the infected host for months or even years after infection, 
which is usually permanent. 
Sporulated oocysts, tachyzoites, and tissue cysts all serve as infective agents. Feral 
and domestic cats will continue to be a source of infection to humans. Any cat, no matter 
how well fed and protected, may be passing oocysts of T. gondii. Particularly at risk are 
individuals such as children at play, who may come in close contact with areas likely to 
be contaminated with cat feces (i.e., sand boxes, garden soil), and adults responsible for 
changing "kitty litter". Ripe oocysts from fecal contamination of the environment by cats 
provide infection for grass-eating animals (i.e., cow, sheep). This form of the parasite 
easily withstands environmental extremes; oocysts can survive freezing and thawing 
conditions, allowing them to remain viable for years (Hays, 1996). In addition to the oral 
route of infection, congenital infection may occur if a woman acquires acute 
toxoplasmosis while she is pregnant. Furthermore, insects such as filth flies and 
cockroaches can mechanically transfer oocysts to human food (Roberts and Janovy, 
1996). Infections via tissue cysts occur when raw or undercooked meat is eaten. House 
cats can be infected this way when they eat rodents and birds. Humans can be infected 
by ingesting undercooked meat products. Although beef is certainly a potential source of 
infection, pork and lamb are much more likely to be contaminated (Roberts and Janovy, 
1996). 
Immunity and Pathogenesis 
In the primary infection, the proliferation of trophozoites results in the death of 
involved host cells and the stimulation of a mononuclear inflammatory reaction (Plorde, 
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1990). The most common symptoms of acute toxoplasmosis are painful, swollen lymph 
glands, fever, headache, muscle pain, anemia, and sometimes lung complications. This 
syndrome can be mistaken easily for the flu. In immunodeficient hosts, rapid 
proliferation of the parasites continues, producing numerous and widespread foci of 
tissue necrosis (Plorde, 1990). The consequences are most serious in organs such as the 
brain, where the potential for cell regeneration is limited. 
In normal hosts, T. gondii infection is controlled by a strong cell-mediated immune 
response that shuts down replication of the tachyzoite stage and leads to the formation of 
dormant cysts (Roberts and Janovy, 1996). Cell-mediated immunity is thought to be the 
major host factor preventing reactivation of chronic infection as well as determining 
acquired resistance to reinfection (Gazzenelli et al., 1991). Both CD4+ and in particular 
CD8+ T-cell responses are involved in the resolution of infection (Khan et al., 1994). 
Natural killer (NK) cells also appear to play a critical role during T. gondii infection by 
producing interferon gamma (IFN-y), which in turn activates macrophages into a 
microbicidal state. Studies have implicated IFN-y as the major cytokine which plays a 
protective role during acute infection and prevents reactivation of latent infection 
(Araujo, 1992). Because T. gondii elicits a strong Thi cytokine response, interleukin-2 
(IL-2) and interleukin 12 (IL-12) also appear to be principal mediators against acute 
parasitic infection. IL-2 is required for priming and maintaining the cell-mediated host 
response, and IL-12 is an essential cytokine that stimulates the proliferation of NK cells 
and CD8+ T cells (Araujo, 1992). Chronic infection results when immunity builds up 
sufficiently to depress tachyzoite proliferation and coincides with the formation of tissue 
cysts. These cysts can remain intact for years and produce no obvious clinical effect. 
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Occasionally, a cyst wall will break down, releasing bradyzoites. Most of these are killed 
by host reactions, although some may form new cysts (Roberts and Janovy, 1996). Death 
of the bradyzoites may elicit an intense hypersensitive inflammatory reaction, which in 
the brain is gradually replaced by nodules of glial cells. If many such nodules are 
formed, the host may develop symptoms of chronic encephalitis. Chronic active or 
relapsing infections of retinal cells by tachyzoites causes blind spots and extensive 
infections of the central macular area, which may lead to blindness (Roberts and Janovy, 
1996). Cysts and subsequent cyst rupture in the retina also can lead to blindness. Other 
kinds of extensive pathological conditions such as myocarditis, with permanent heart 
damage and with pneumonia, can occur in chronic toxoplasmosis (Roberts and Janovy, 
1996). 
When an infected person becomes immunosuppressed, such as in AIDS, tissue cysts 
rupture and a rapid dissemination of the parasite occurs. In AIDS, toxoplasmosis is 
thought to originate primarily from reactivation of a chronic infection. This process 
results in excessive cellular destruction producing mass lesions in the CNS, which may 
lead to encephalitis and eventually death (Gazzinelli et al., 1991). Toxoplasmosis is 
currently recognized as a serious opportunistic infections in AIDS patients (Heitman and 
Irizarry, 1997). It has been estimated that as many as 1 in 10 AIDS patients in the United 
States dies of toxoplasmosis (Hays, 1996). Thus, infection with T. gondii can be 
devastating for individuals with AIDS. In these patients, the major immunodeficiencies 
are a severe depletion of CD4+ T lymphocytes and an impaired capacity to produce 
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IFN-y. In addition, any long-term steroid therapy, such as is given to some cancer 
patients, can result in disseminated toxoplasmosis producing ocular toxoplasmosis and 
fatal CNS disorders (Roberts and Janovy, 1996). 
Another tragic form of this disease is congenital toxoplasmosis. If a mother 
contracts acute toxoplasmosis at the time of her child's conception or during pregnancy, 
the parasites often will infect her developing fetus. One out of every 500 pregnant 
women acquires acute toxoplasmosis, and in half of those cases, the infection does spread 
to the fetus (Plorde, 1990). Depending on the stage when the fetus is infected, the end 
result could be an abortion, a still born child, or a child born with some form of mental 
retardation. Of those infected approximately 60% are subclinical, 9% die, and 30% 
suffer severe damage such as hydrocephalus, retinochoroiditis, and mental retardation 
(Roberts and Janovy, 1996). Toxoplasmosis is considered a major cause of human birth 
defects, probably causing more congenital abnormalities in the United States than rubella, 
herpes, and syphilis combined (Roberts and Janovy, 1996). 
The Effects of Antioxidants on Immune Function 
Nutrition has a profound effect on immunity and overall health in animals (Chew, 
1995). Nutritional deficiencies impair responsiveness and, thereby, increase morbidity 
and mortality (Chew, 1995). On the other hand, nutritional supplementation often 
enhances certain aspects of immune function (Chew 1995). A group of vitamins (i.e., 
vitamin E and vitamin C) and minerals (i.e., Se and zinc) have recently received a great 
deal of attention because of their apparent effect on immunity and disease etiology 
(Chew, 1995). 
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The immune system protects the host from invasion and damage from a wide range 
of microorganisms (parasites, bacteria, molds, yeasts, fungi and viruses) by a highly 
complex biological response (Grimble, 1997). The response involves cellular 
proliferation, enhanced protein synthesis and inflammatory mediator production, and 
widespread physiological changes (Grimble, 1997). Although the immune system has a 
protective role for the host, some of the actions of the system have the potential to 
damage the host. Highly reactive oxygen species such as the superoxide anion radical 
(O2"), hydroxyl radical (OH), hydrogen peroxide (H2O2) and singlet oxygen (O2) are 
continuously produced in the course of normal aerobic cellular metabolism (Chew, 
1995). In addition, phagocytic granulocytes undergo respiratory burst to produce oxygen 
radicals to destroy intracellular pathogens. These activated oxygen species (AOS) can 
damage genetic material, inactivate membrane-bound enzymes, and cause lipid 
peroxidation (Florence, 1995). Lipid peroxidation in cell membranes destroys critical 
cellular components and affects membrane fluidity. Loss of membrane fluidity in 
lymphocytes has been directly related to decreased ability of lymphocytes to respond to 
immunological challenges (Garewal, 1997). Other sources of free radicals include 
strenuous exercise, detoxification, exposure to certain chemicals, radiation, ultraviolet 
light, alcohol, cigarette smoke, air pollutants, and high fat diets (Garewal, 1997). If these 
oxidative products are not eliminated, they can damage healthy cells, and thus, decrease 
immune function. Antioxidants serve to stabilize these highly reactive free radicals, 
thereby maintaining the structural and functional integrity of cells (Chew, 1995). 
Therefore, antioxidants are very important to the immune defense and health of animals 
(Chew, 1995). 
9 
Many degenerative diseases such as cancer, inflammatory joint disease, asthma, 
diabetes, degenerative eye disease, and atherosclerosis are believed to be caused, or at 
least exacerbated, by activated oxygen species (AOS) (Florence, 1995). For instance, in 
carcinogenesis, the initial mutagenic event often involves an AOS or some oxidative 
chemical (the "ultimate" carcinogen) produced by the cytochrome P-450 system 
(Florence, 1995). Metastasized cancer cells cannot attach to tissue without a concomitant 
oxidation process. There is a large body of evidence that oxidative processes, especially 
lipid-peroxidation, are involved in the pathogenesis of atherosclerosis (Florence, 1995). 
Atherosclerosis involves the deposition of fatty deposits (atheroma) in blood vessels. 
Atheroma; however, cannot form unless the endothelium is first damaged by AOS from 
white blood cells (i.e, macrophages) and lipid peroxides (Florence, 1995). Considering 
the involvement of activated oxygen species (AOS) in many degenerative diseases, it is 
not surprising that epidemiological and clinical studies have found that dietary 
antioxidants have a protective effect (Florence, 1995). For instance, several studies have 
indicated that a high intake of antioxidants leads to a decreased cardiovascular disease 
risk (Poppel et al., 1994). There also is evidence for an association between low vitamin 
intake and subsequent risk of developing some forms of cancer (Madhavi et al., 1995). 
The course of several other diseases, such as arthritis, can be altered by nutritional 
intervention (Kelley and Bendich, 1996). 
Evidence has accumulated suggesting that patients infected with the human 
immunodeficiency virus (HIV) are under chronic oxidative stress (Pace et al., 1995). 
Changes in components of the antioxidant defense system and increased levels of 
oxidation products have been observed in asymptomatic HIV—infected patients and in 
patients with acquired immunodeficiency syndrome (AIDS) (Pace et al., 1995). The role 
of oxidative stress in HIV disease appears to be quite broad and may involve alterations 
in viral replication, immune function, apoptosis, weight loss, and critical aspects of redox 
and glutathione-dependent metabolism (Pace et al. 1995). Furthermore, opportunistic 
infections, which induce a sequel of inflammatory responses, directly or indirectly, 
promote oxidative stress. These pro-oxidative conditions cause activation of free radical-
producing immune cells, enhancement of viral replication, and weakening of the 
antioxidant defense system (Pace et al., 1995). Thus, nutrition plays an important role in 
the overall outcome of HIV-infection. Mega doses and multiple combinations of 
vitamins and minerals have been commonly used in an attempt to interrupt or delay 
progression of the disease because many vitamins have immune-modulating properties 
(antibody production, lymphocyte proliferation, and cytokine production) and lower free 
radical burden (Kelley and Bendich, 1996). Epidemiological research on the relationship 
between dietary nutrient intake and the progression of HIV to AIDS suggests that 
increased intake of vitamins (both from food and supplements) is associated with a 
significantly decreased progression rate to AIDS (Harbige, 1996). 
Humans are well endowed with antioxidant defenses against activated oxygen 
species. These antioxidants, or free radical scavengers, include the enzymes catalase, 
superoxide dismutase, and the Se-dependent glutathione peroxidase (GSHPx). However, 
the antioxidant defenses of the body do not offer complete protection for the host tissues 
against the oxidative molecules produced by the immune system (Grimble, 1997). The 
capacity of the host to improve antioxidant defenses will depend in part upon the 
concomitant intake of nutrients such as tocopherols (vitamin E), ascorbic acid (vitamin 
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C) and (3-carotene (Grimble, 1997). In addition, the intake of metallic micronutrients, 
such as Se, influences the activity of antioxidant enzymes such as the Se-dependent 
glutathione peroxidase (GSHpx), which further improve antioxidant defenses. 
Vitamin E 
Vitamin E, an essential fat-soluble vitamin, includes eight naturally occurring 
compounds in two classes designated as tocopherols and tocotrienols with different 
biological activities (Meydani, 1995). Of the eight compounds that have been isolated 
from plant sources that have vitamin E activity, d-a-tocopherol has the greatest biological 
activity and is the most widely available form of vitamin E in food (Weber et al., 1997). 
In mammalian cells, a-tocopherol is mainly located in mitochondrial fractions and in the 
endoplasmic reticulum, whereas little is found in the cytosol and peroxisomes (Chew, 
1995). Vitamin E is usually expressed in international units (IU), and 1 mg of the natural 
form of d-a-tocopherol has a biopotency of vitamin E equal to 1.49 IU (Meydani, 1995). 
The recommended dietary allowance (RDA) of vitamin E for male adults is 10 mg (15 
IU) per day and for female adults is 8 mg (12 IU) (Weber et al., 1997). Relative to other 
fat-soluble vitamins, vitamin E is safe; high doses of vitamin E provide essentially no 
toxicity (Meydani, 1995). Vegetables and seed oils including soybean, safflower and 
corn, sunflower seeds, nuts, whole grains, and wheat germ are the main sources of the 
tocopherols (Meydani, 1995). 
The most widely accepted biological function of vitamin E is its antioxidant 
property (Meydani, 1995). Vitamin E, functioning as an antioxidant and free radical 
scavenger, can inhibit lipid peroxidation and decrease the burden of free radicals on 
immune cells by both quenching and reacting with oxygen radicals (Wang and Watson, 
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1994). During its action as a chain-breaking antioxidant in membranes, vitamin E is 
consumed and converted to the radical vitamin E, which in turn could be restored to 
vitamin E by vitamin C or other antioxidants (Wang and Watson, 1994). 
Excessive alcohol (ETOH) consumption has been associated with a lowered 
resistance of the host to infectious diseases (Wang et al., 1994b). Alcohol consumption 
significantly stimulates lipid peroxidation and free radicals. Wang et al. (1994b) 
demonstrated that vitamin E supplementation significantly normalized lipid peroxidation 
and the generation of free radicals in ETOH-fed rats (Wang et al., 1994b). Furthermore, 
vitamin E supplementation significantly improved T- and B-cell proliferation, and 
slightly improved immunoglobulin production, which had been significantly reduced by 
dietary ETOH (Wang et al., 1994b). In addition to its antioxidant property, vitamin E 
may have other important roles in biological processes such as the stimulation of the 
immune response, the suppression of inflammation, and DNA synthesis (Dutta-Roy et al., 
1994). Thus, vitamin E supplementation may improve the host defense against 
opportunistic infections by enhancing the immune response, which often is suppressed by 
ETOH ingestion (Wang et al., 1994b). 
Several animal studies have shown that vitamin E is essential for normal function of 
the immune system. Deficiency in vitamin E is associated with a decline of the immune 
response, whereas higher than required amounts have stimulatory effects (Meydani, 
1995). Dietary supplementation with vitamin E has been associated with increased 
lympho-proliferative response to mitogens, T-helper (Th) activity, antibody synthesis, 
neutrophil antimicrobial activity, and macrophage phagocytic activity (Wang and 
Watson, 1994). Chew et al. (1995) demonstrated that calves supplemented with 125 to 
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500 mg of a-tocopherol/d had increased T-cell and B-cell mitogenesis. Bovine 
peripheral blood mononuclear cells incubated in vitro with 55-110 (ig of a-tocopherol 
had enhanced production of IgM and upregulation of IL-1 production (Chew, 1995). In 
other studies, increased vitamin E intake in mice (10 times the recommended diet level 
for 50 days) was associated with increased antibody responses (particularly IgG), T-
helper cell function, and enhanced cooperative effects between T and B cells. 
Furthermore, vitamin E administered to mice intraperitoneally enhanced the mitogenic 
response to B-cell and T-cell mitogens, and this was achieved at an estimated 10 to 50 
times the normal dietary intake (Harbige, 1996). 
Animal studies have indicated that supplementation of the diet with vitamin E, at 
levels which are several fold greater than recommended daily requirements, increased the 
resistance to a number of infectious organisms (Grimble, 1997). For example, vitamin E 
protected chicks against experimental Escherichia coli infection at doses 3 and 6 times 
the normal dietary intake (Harbige, 1996). Following this discovery, increased resistance 
to infection following supplementation with vitamin E was recorded for Histomonas 
meleacridis in chicks and turkeys, Chlamydia in sheep and lambs, E. coli and Treponema 
hyodysenteriae in pigs, and Diplococcus pneumoniae and Mycoplasma pulmonis in 
rodents. A similar phenomenon also may occur in humans since epidemiological 
evidence shows lower incidence of infectious disease in subjects with high plasma 
tocopherol concentrations (Grimble, 1997). 
Considerable evidence indicates that aging is associated with altered regulation of 
and decline in the immune response, which results in increased incidences of infectious 
diseases (Meydani, 1995). Supplementation of healthy subjects who were at least 60 
years old with 800 mg d-a-tocopherol daily for 30 days increased three indices of T-cell-
mediated function for which age-associated decreases have been reported (i.e., the 
delayed-type hypersensitivity skin test, the mitogenic response to concanavalin A, and II-
2 production (Meydani, 1995). This immunostimulatory effect of vitamin E 
supplementation in elderly subjects is associated with an increased resistance to disease 
(Meydani, 1995). In a double-blind placebo-controlled study, an enhancement of the 
immune response also was observed in healthy young subjects after 6 months' 
supplementation with 400 IU daily vitamin E (Meydani, 1995). In other studies, humans 
receiving 150 IU of vitamin E for 28 days showed a 50% increase in T-cell numbers 
(Harbige, 1996). 
Acquired immune deficiency syndrome (AIDS) is a disease of presumed retroviral 
etiology, characterized by immune dysfunction and associated with opportunistic 
infections and eventual death (Wang et al., 1994a). Profound weight loss, cachexia, 
multiple nutrient deficiencies and protein calorie malnutrition are frequently nutritional 
disorders found in AIDS patients (Wang et al., 1994a). Patients at various stages of HIV 
infection have low serum vitamin E concentrations (Bogden et al., 1990). High intake of 
vitamin E was shown to enhance the immune response and reduce the size and number of 
carcinogen-induced tumors, which had been increased in mice with murine AIDS (Wang 
et al., 1994a). In addition, increased dietary vitamin E restored tissue concentrations of 
vitamin A, vitamin E, zinc and copper, which had been suppressed by murine AIDS. 
Vitamin E supplementation also partially restored secretion of important cytokines such 
as IL-2 and IFN-y. Interleukin-2 and IFN-y have distinct biological activities such as 
activating phagocytosis by macrophages and neutrophils, and increasing natural killer 
(NK) cell activity (Wang et al., 1994a). Furthermore, vitamin E treatment of infected 
mice reduced levels of IL-4, IL-5, IL-6 and TNF-a, which were elevated by retroviral 
infection in non-supplemented mice (Wang et al., 1994a). These results suggest a 
possible role for vitamin E as a therapeutic nutrient to help ameliorate undernutrition and 
immune dysfunction caused by retroviral infection in AIDS patients (Wang et al., 1994a). 
Several experimental and epidemiological studies have suggested that vitamin E 
might reduce the risk of cancer. A population-based control study of oral and pharyngeal 
cancer conducted in the United States indicated that the use of vitamin E supplements 
(100 IU vitamin E per day for 1 to 2 years) was associated with a 50% risk reduction for 
oral and pharyngeal cancer (Weber et al., 1997). In the Iowa Women's Health Study, 
investigators reported that use of vitamin E supplements containing more than 100 IU 
was associated with a highly significant reduction in the risk of colon cancer (Weber et 
al., 1997). It has been suggested that vitamin E inhibits mutagenesis and cell 
transformation primarily through its antioxidant function, eliminating oxygen free 
radicals and decreasing DNA damage (Meydani, 1995). 
Selenium 
Selenium is an essential dietary micronutrient required for normal growth, 
development and for the prevention of such deficiency diseases as liver necrosis and 
muscular dystrophy (Spallholz et al., 1973). Dietary sources of Se include meats (kidney 
and liver), seafood (swordfish and tuna), and vegetables such as cabbage, celery, and 
radish (Madhavi et al., 1995). Selenium is present in organic form in these sources, 
which is the major nutritional source of Se in animals and humans (Madhavi et al., 1995). 
Selenium functions as an antioxidant at the cellular level. Selenium is incorporated 
into a number of functionally active selenoproteins, including the enzyme glutathione 
peroxidase (GPx- which functions (in conjunction with vitamins A, C, E) as a cellular 
protector against oxidative damage. Glutathione peroxidase is a key enzyme involved in 
the reduction of several organic hydroperoxides (ROOH) and hydrogen peroxide (H2O2) 
(Gamain et al., 1995). Such peroxides are a source of potentially injurious free radicals, 
which can cause peroxidation of polyunsaturated fatty acids in the cell membrane. 
Selenium-GPx is localized in the cytosol and mitochondria of most cells with 
erythrocytes and hepatocytes having particularly large amounts (Dworkin, 1994). The 
activity of glutathione peroxidase is closely related to the dietary intake of Se above the 
normal nutritional range (Levander, 1992). 
A number of studies have documented that Se affects the immune functions of a 
host in vivo and that Se deficiency and supplementation correlate, respectively, with a 
decreased or an increased resistance of a host to challenge with foreign antigens 
(Kiremidjian-Schumacher et al., 1994). For instance, recent animal studies by Beck et al. 
(1994) have shown that mice fed on a Se-deficient diet developed inflamed hearts within 
1 week of being exposed to a benign coxsackie virus (a family of viruses also thought to 
be responsible for Keshan disease). No such observations were made in the control 
group of mice fed on a normal diet. These results demonstrate that host Se status was 
important in determining the outcome of viral infection with the coxsackie virus. 
Selenium deficiency also has been shown to decrease the resistance of animals to a 
number of other pathogenic infections. For example, when Se-deficient and Se 
supplemented mice were given intravenous injections of Candida albicans, deaths of the 
Se-deficient animals started after 2.5-3.5 d compared with 7-8.5 d in the Se-supplemented 
animals (Boyne and Arthur, 1986). Significantly more microorganisms were found in the 
kidney, liver, and spleen of the Se-deficient mice compared with the same organs of Se-
supplemented animals. Selenium deficiency also was demonstrated to impair the ability 
of mouse neutrophils to kill C. albicans in in vitro tests (Boyne and Arthur, 1986). Thus, 
it was concluded that Se-deficient mice were more susceptible to Candida albicans 
infection. Further studies have indicated that Se-deficient mice were more susceptible to 
Diplococcuspneumonia Type 1 infection, and increased mortality was observed in Se-
deficient rats after intraperitonel injection of Staphylococcus aureus (Boyne and Arthur, 
1986). 
Studies have indicated that Se supplementation is beneficial in improving the 
immune response in humans and mice. For instance, increased dietary Se has been 
shown to enhance immunity during microbial infection (Davis et al., 1998). The 
beneficial effect of Se was observed in mice infected with the protozoan parasite, 
Trypanosoma cruzi. Mice receiving 4 or 8 ppm Se (sodium selenate) administered in 
their drinking water exhibited the highest overall survival of 60% as compared to 0% 
survival in the non-supplemented groups (Davis et al., 1998). Also, the Se supplemented 
groups had reduced parasitemias when compared to the non-supplemented groups. 
Selenium also has been shown to alter the expression of the high affinity interleukin 2 
receptor (IL-2-R) and its subunits, cell proliferation, and clonal expansion of cytotoxic T-
lymphocytes in mice (Roy et al., 1994). Spallholz et al. (1973) demonstrated that dietary 
supplementation with Se significantly increased anti-sheep red blood cell (SRBC) IgM 
and IgG antibody titers in mice. In a further study, Spallholz et al. (1975) demonstrated 
that Se administered to mice intraperitoneal^ (5 |_ig) enhanced the primary immune 
response to the sheep red blood cell antigen. Enhancement of the primary immune 
response was greatest when Se was administered prior to or simultaneously with the 
antigen (Spallholz et al., 1975). Other studies indicated that supplementation of lambs 
and ewes with Se at high non-physiological levels enhance IgG responses to a variety of 
infectious challenges (Harbige, 1996). 
In humans, the immuno-enhancing effects of Se require supplementation above 
levels acquired by normal dietary intake. Dietary supplementation with Se in humans 
(200(ig/day for 8 weeks) resulted in a 118% increase in cytotoxic lymphocyte-mediated 
tumor cytotoxicity and an 82.3% increase in natural killer cell activity as compared to 
normal baseline values (Kiremidjian-Schumacher et al., 1994). Further studies indicated 
that dietary supplementation with Se in humans above levels acquired by normal dietary 
intake resulted in a significant augmentation of the ability of peripheral blood 
lymphocytes to respond to mitogen (Roy et al., 1994). 
Selenium deficiency is common in HIV positive patients as documented by low 
plasma and red blood cell levels of Se and diminished activity of glutathione peroxidase 
(Dworkin, 1994). Patients with AIDS tend to have more severe deficits than those with 
earlier stages of HIV infection. Both gastrointestinal malabsorption and deficient dietary 
intake in AIDS patients undoubtedly contribute to the development of Se deficiency. It 
has been suggested that in patients with AIDS, that Se deficiency may be associated with 
impaired immune function, reduced T-cell counts, as well as various specific disorders 
such as oral candidiasis (Dworkin, 1994). Selenium supplementation in HIV-infected 
patients has been shown to cause symptomatic improvements, especially in appetite and 
intestinal functions, and to possibly slow the course of the disease (Garewal, 1997). 
Selenium supplementation during AIDS also has been shown to improve cardiac 
dysfunction (Dworkin, 1994). For example, Keshan disease (a myocardiopathy 
associated with children) is seen in low-Se regions of China and can be prevented by Se 
supplementation (Foster and Sumar, 1997). This similar form of cardiomyopathy also 
has been seen frequently in AIDS patients. Therefore, it has been suggested that Se 
supplementation during the course of HIV infection should be a form of supportive 
therapy (Garewal, 1997). 
Selenium also is emerging as a dietary factor that may prove to be of major 
significance as a prophylactic agent against cancer (Madhavi et al., 1996). Selenium has 
been found to be capable of inhibiting and or retarding tumorigenesis in a variety of 
experimental animals. For example, Medina et al. (1983) demonstrated that Se was 
anticarcinogenic in mice both in vivo and in vitro. Dietary supplementation of mice with 
2.0 ppm of Se markedly inhibited tumor production in mice, and this level of Se was not 
detrimental to the host (Medina et al., 1983). Moreover, high levels of Se given in the 
drinking water protected against UV-light -induced skin cancer in hairless mice 
(Levander, 1987). The protective effect of Se against free-radical injury is primarily 
attributed to the selenoenzyme GSH-Px. 
The Combined Effects of Vitamin E and Se 
Vitamin E has a complex relationship with Se (Chang et al., 1994). The two exert 
similar antioxidant effects in cells, but via independent biochemical pathways and in 
different locations (Chang et al., 1994). Vitamin E acts on the biomembrane and protects 
lipid membranes, whereas Se acts in the form of Se-dependent glutathione peroxidase 
(GPX) in the cytoplasm and protects -SH groups in membrane proteins against oxidation 
(Zhu et al., 1992). Furthermore, vitamin E prevents lipid peroxidation more effectively 
than Se, whereas Se prevents free radical production more effectively than vitamin E 
(Zhu et al., 1992). Thus, while each can have a sparing influence on the need for the 
other, neither can fully compensate for the other (Chang et al., 1994). 
The results of several investigations have supported the conclusion that dietary 
deficiencies of vitamin E and/or Se are associated with an impairment of the immune 
response (Chang et al. 1994). There is evidence that in the chicken, dietary deficiencies 
of these nutrients (either individually or together) can impair humoral immunity, cell-
mediated mechanisms, mitogenic responsiveness, primary lymphoid organ development, 
and disease resistance (Chang et al., 1994). A combined dietary deficiency of vitamin E 
and Se was shown to result in a consistent depression of splenocyte proliferation in 
response to the T cell mitogens ConA and to the B cell mitogen, lipopolysaccharide 
(Chang et al., 1994). The proliferative response could be fully reconstituted only after 
vitamin E and Se supplementation. Dietary deficiencies also resulted in a decreased 
proportion of peripheral T cells and significantly decreased the number of CD4+ 
peripheral blood leukocytes (PBL) (Chang et al., 1994). Another known physiological 
consequence of a-tocopherol or Se deficiency is reduced neutrophil activity (Hogan et 
al., 1992). Both antioxidants protect neutrophils from the destructive action of toxic 
oxygen molecules necessary for intracellular kill of ingested pathogens. Dietary 
supplementation of cattle with Se results in a more rapid neutrophil influx into milk 
following intramammary bacterial challenge, and increases intracellular killing of 
ingested bacteria by neutrophils (Hogan et al., 1993). Dietary supplementation of early 
lactation cows with vitamin E results in increased bactericidal activity by bovine blood 
neutrophils (Hogan et al., 1993). The supplementation of deficient animals with Se and/or 
vitamin E improves the function of neutrophils in other animals, such as in chickens and 
sheep (Finch and Turner, 1996). The ability of phagocytes to migrate to the site of 
infection or inflammation may also be affected by an animal's Se/vitamin E status. 
Selenium deficiency reduced the random migration and chemotactic responses of caprine 
neutrophils, and both responses could be reversed by Se supplementation (Finch and 
Turner, 1996). 
Vitamin E and Se both have been shown to have immunostimulatory effects in a 
variety of species when administered in quantities in excess of established dietary 
requirements (Sheffy and Schultz, 1979). Wise and Tomasso (1993) reported that 
fmgerling channel catfish fed diets deficient in vitamin E were more susceptible to 
peroxidation than fish fed diets that met or exceeded vitamin E recommendations. 
Hepatic Se-dependent glutathione peroxidase activity was suppressed in fish fed diets 
deficient in Se when compared to fish fed diets containing recommended or higher levels 
of Se (Wise and Tomasso, 1993). Intracellular superoxide anion production by 
macrophages (an indicator of disease resistance) was higher in fish fed the diet fortified 
with four times the recommended levels of both nutrients than in fish fed the other diets 
(Wise and Tomasso, 1993). 
Many of the studies of the effects of Se and vitamin E on immune responses have 
investigated their influence on antibody production. Studies in rodents have revealed a 
synergistic effect when both nutrients were administered (Finch and Turner, 1996). 
Combined supplementation with Se and vitamin E has been particularly effective in 
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raising the antibody responses of animals (chickens, pigs, and horses) previously 
deficient in both nutrients (Finch and Turner, 1996). The immune responses of dogs can 
be influenced by vitamin E and Se nutrition. Neutralizing antibody titers following 
vaccination with a canine distemper-infectious hepatitis virus vaccine were lower during 
vitamin E and Se deficiency at each period tested for a 28-day-period post-immunization 
(Sheffy and Schultz, 1979). The appearance of measurable antibody after immunization 
was delayed in vitamin E-Se deficient dogs, and the secondary immune responses also 
were reduced in the deficient dogs (Sheffy and Schultz, 1979). 
Free radical catalyzed lipid peroxidation is a continual biological process causing 
damage to cellular and intracellular structures (Sheffy and Schultz, 1979). This process 
can act to destroy certain enzymes and other intracellular components, as well as to alter 
membrane structures. Vitamin E alone and in concert with Se can inhibit these processes. 
It has been demonstrated that the oxidative damage in many tissues is more severe during 
double Se and vitamin E deficiency than with deficiency of either antioxidant alone 
(Ndiweni and Finch, 1995). 
Studies have shown that Se and vitamin E status also can have a profound impact 
on the ability of a host to resist acute infectious disease (Levander et al., 1995). A low 
vitamin E/Se status has been associated with increased vulnerability of dairy cattle to 
mastitis (Ndiweni and Finch, 1995). Since polymorphonuclear leucocytes (PMN) 
provide the major cellular defense mechanism within the mammary gland, the effect of in 
vitro supplementation with vitamin E and Se on the function of these cells was 
investigated. Both vitamin E and Se enhanced the functions of mammary gland 
macrophages and peripheral lymphocytes (Ndiweni and Finch, 1996). Furthermore, a 
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reduction in the incidence of subclinical infections also was associated with a high 
vitamin E/Se status (Ndiweni and Finch, 1996). 
INTRODUCTION 
The protozoan parasite Toxoplasma gondii is common in nature and highly 
prevalent in humans throughout the world (Araujo, 1992). Approximately 50% of the 
human population of the United States has been infected (Plorde, 1990). After acute 
infection with T. gondii, the parasite forms cysts in multiple tissues and organs, which 
persist for years and probably for the entire life span of the individual (Huskinson-Mark 
et al., 1991). Individuals with a normal functional immune system are able to contain 
infection by T. gondii but immunocompromised patients are at risk of developing life-
threatening toxoplasmosis. Thus, toxoplasmosis, particularly toxoplasmic encephalitis, 
has emerged as a major cause of morbidity and mortality in patients with the acquired 
immunodeficiency syndrome (AIDS) (Suzuki and Joh, 1994). When the host is 
immunocompromised, as in AIDS or during immunosuppressive therapy, cysts rupture 
and a rapid dissemination of the parasite occurs (Gazzinelli et al., 1991). This process 
results in excessive cellular destruction, producing lesions in many organs, and may 
result in pneumonia, encephalitis, and death (Gazzinelli et al., 1991). 
Since immunocompetent individuals do not suffer apparent untoward effects from 
their infection with T. gondii, it is clear that the immune response is critical for 
prevention of toxoplasmic encephalitis (Suzuki et al., 1996). The major mechanism of 
resistance to T. gondii is cell-mediated with the participation of CD8+ and CD4+ T cells 
(Araujo, 1992). In addition, the cytokine IFN-y plays a crucial protective role during 
acute infection and in the prevention of reactivation of a latent infection (Araujo, 1992). 
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Humoral immunity also is known to be involved in resistance against acute 
toxoplasmosis (Suzuki et al., 1996). 
Nutrition and nutritional status can have profound effects on immune function, 
resistance to infection, and autoimmunity in man and animals (Harbige, 1996). Nutrients 
may enhance or depress immune function depending on the nutrient and level of its 
intake (Harbige, 1996). Vitamin E and Se both have been shown to have 
immunostimulatory effects in a variety of species when administered in excess of 
established dietary requirements (Sheffy and Schultz, 1979). Both nutrients have been 
shown to influence antibody production, lymphocyte proliferation, cytokine production, 
and numbers of the specific subgroups of white blood cells (Kelley and Bendich, 1996). 
Vitamin E is a fat-soluble vitamin which is located in cell membranes, where it 
protects membrane polyunsaturated fatty acids from peroxidation (Ndiweni and Finch, 
1995). Studies in various animals have demonstrated that vitamin E deficiency impairs 
cellular and humoral immunity. Deficiency of the vitamin also is associated with an 
increased incidence of disease (Grimble, 1997). However, vitamin E supplementation 
brings about the opposite effect. Supplementation of the diet with vitamin E at levels 
which are several fold greater than normal results in increased resistance to a number of 
pathogens (Grimble, 1997). For example, resistance of chickens and turkeys to 
Escherichia coli and of mice to pneumococci was enhanced by vitamin E 
supplementation. Furthermore, increased intake of vitamin E has been shown to enhance 
interleukin-2 production and the delayed hypersensitivity reaction, lymphocyte 
proliferation in response to concanavalin A (Con A) and lipopolysaccharide (LPS) 
(Grimble, 1997). 
Selenium is a co-factor of the cytosolic enzyme glutathione peroxidase (GSHPx) 
which is essential for the detoxification of hydrogen and lipid peroxides (Ndiweni and 
Finch, 1995). A number of studies have documented that Se affects the immune 
functions of a host and that Se deficiency and supplementation correlate, respectively, 
with a decreased or an increased resistance of a host to challenge with foreign antigens 
(Kiremidjian-Schumacher et al., 1994). Selenium supplementation studies performed 
with mice, lambs, and ewes indicate that at high non-physiological intake Se enhances 
IgG responses to a variety of infectious challenges (Harbige 1996). Selenium also has 
been shown to enhance the capacity of a host to generate cytotoxic lymphocytes (CTL) 
and macrophages and to destroy tumor cells (Kiremidjian-Schumacher et al., 1994). 
Notwithstanding the demonstrated beneficial effects of vitamin E and Se 
supplementation on immune function, a few studies have indicated that deficiencies of 
vitamin E and Se can increase the resistance of animals to certain microorganisms 
(Boyne and Arthur, 1986). Selenium deficiency was shown to increase the survival of 
rats infected with Salmonella typhimurium and mice infected with Plasmodium bergeii or 
Listeria monocytogenes (Boyne and Arthur, 1986). Vitamin E deficiency protected mice 
against the intraerythrocytic parasite Plasmodium yoelii (murine malaria) by markedly 
improving the survival of infected mice, especially when the mice were concurrently fed 
peroxidizable fat such as fish or linseed oil (Levander, 1992). Recent studies have 
provided evidence that Plasmodium does possess a parasitic selenium-dependent 
glutathione peroxidase to protect against the deleterious effects of oxidative stress 
(Gamain et al., 1995). Higher glutathione peroxidase activities were observed in the 
malarial parasite after selenium supplementation. After Se supplementation, with either 
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sodium selenite or selenocystine an increase in parasitic growth was observed (Gamain et 
al., 1995). 
Patients infected with the human immunodeficiency virus (HIV) typically 
experience chronic oxidative stress (Pace and Leaf, 1995). Oxidative stress is a 
pathologic phenomenon caused by a relative overload of oxidants, i.e., reactive oxygen 
species (Pace and Leaf, 1995). Reactive oxygen species (ROS) are toxic via their effects 
on cellular components such as the denaturation of proteins, membrane lipids, and DNA 
(Garewal, 1997). Any antigenic or regulatory stimulus to polymorphonuclear leukocytes, 
or T-cell activity, will increase the expression of ROS (Greenspan and Aruoma, 1994). 
Therefore, the high level of antigenic and cytokine activity in HIV/AIDS results in the 
production of substantial levels of superoxides, hydrogen peroxide and hydroxyl radicals. 
Additional sources of ROS include the products of peroxidation and sequelae of 
inflammatory responses induced by opportunistic infections (Greenspan and Aruoma, 
1994). Thus, infection with the intracellular pathogen T. gondii would be expected to 
further exacerbate oxidative stress in HIV/AIDS individuals. As antioxidants, vitamin E 
and Se function as free radical scavengers and help prevent ROS from causing further 
cellular damage. Vitamin E and Se supplementation in HIV-infected patients has been 
shown to reduce free radical concentrations, lipid peroxidation and cause symptomatic 
improvements (Garewal, 1997). Therefore, the reduction of oxidative stress by 
antioxidant treatment is suggested as supportive therapy in early as well as in advanced 
stages of HIV infection (Garewal, 1997). 
The high incidence of toxoplasmosis among AIDS patients has served as an 
impetus to identify new treatment strategies (Hu skin son-Mark et al., 1991). The present 
study was conducted to determine if vitamin E and Se might provide a beneficial effect in 
a murine model of chronic infection with T. gondii. At present, the only model for 
evaluation of the activity of therapeutic agents against the cyst form of T. gondii is the 
chronically infected laboratory animal (Huskinson-Mark et al., 1991). In earlier studies, 
vitamin E and Se were shown to provide protective activity against another intracellular 
parasite, Trypanosoma cruzi (Davis et al., 1998 and Hou, 1997). Dietary 
supplementation of vitamin E and Se in mice infected with T. cruzi resulted in increased 
longevity, decreased parasitemias and reduced weight loss during infection. In the 
present study, kinetics of T. gondii infection in mice were assessed by calculating percent 
weight loss, tissue cyst numbers and severity of tissue pathology. 
MATERIALS AND METHODS 
Mice 
Swiss Webster mice were obtained from Hilltop Laboratories (Scottsdale, PA), and 
C57BL/6J mice were obtained from The Jackson Laboratory (Bar Harbor, ME). These 
two different strains of mice were chosen because Swiss Webster are not known to 
develop toxoplasmic encephalitis, whereas the C57BL/6J mice are more susceptible to T. 
gondii with the development of TE. All mice were females and 5 to 6 weeks of age when 
used. In addition, the mice were housed in groups (2 or 5 mice per group) in plastic box 
cages and provided rodent chow and water ad libitum. 
Toxoplasma gondii Infection 
Oocysts of the ME49 strain of T. gondii were used to study chronic infections in 
mice. The oocysts of the ME49 strain was kindly provided by Dr. David Lindsay of the 
Virginia-Maryland Regional College of Veterinary Medicine, Virginia Tech (Blacksburg, 
Virginia). Prior to inoculation of intact oocysts into mice, the ME49 oocysts were 
washed with 10 ml of sterile DPBS (Dulbecco's Phosphate Buffered Saline; Sigma 
Chemical Co., St. Louis, Missouri), and the vial was then centrifuged at 1800 rpm for 15 
minutes. The supernatant was removed and discarded. This washing procedure was 
repeated, and the pellet containing oocysts was resuspended in 5 ml of sterile of DPBS. 
Oocysts were counted using a hemacytometer. 
After washing and counting the oocysts, an infection inoculum of 103 or 104 was 
administered intraperitoneally (i.p), subcutaneously (s.c) or orally to each mouse. 
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Experimental Design 
The efficacy of vitamin E alone and in combination with Se was examined in three 
sets of experiments. For each antioxidant combination, a selected dose that had 
previously been found to be optimal in Trypansoma cruzi-infected mice was used (Davis 
et al., 1999 and Hou, 1997). 
In the first phase of the study, 35 Swiss Webster mice (7 mice per group) were used 
to investigate the effect of dietary supplementation with antioxidants during chronic 
infection with T. gondii. Upon arrival, mice were randomly separated into 10 cages of 2 
or 5 mice each and immediately placed on one of the following diets: 
GROUP 1 
(CONTROL) 
49 IU/kg Vitamin E and 0.2 ppm Se 
(Daily Recommended Allowance) 
GROUP 2 
(Deficient Diet) 
Vitamin E and Se Deficient 
GROUP 3 
(Se Diet) 
8 ppm Sodium Selenate 
GROUP 4 
(Vitamin E Diet) 
400 IU/kg Vitamin E 
GROUP 5 
(Vitamin E and Se Diet) 
400 IU/kg Vitamin E and 8 ppm Sodium Selenate 
The control diet consisted of normal laboratory rodent chow (Purina Rodent Chow 
#5001, Purina Mills, Richmond, IN) containing 49 IU/kg of vitamin E and 0.2 ppm Se. 
The deficient diet contained Purina rodent chow that had 0 IU/kg of vitamin E (#5000, 
Purina Mills, Richmond, IN) and 0 ppm of Se. The vitamin E diet consisted of Purina 
rodent chow supplemented with 400 IU/kg vitamin E (#5827, Purina Mills, Richmond, 
IN), and the Se diet consisted of 8 ppm of sodium selenate (Sigma Chemical Co.). 
Sodium selenate was administered to the relevant groups in their drinking water. The 
vitamin E and Se diet consisted of 400 IU/kg of vitamin E (food) and 8 ppm sodium 
selenate (water). Food and water were provided ad libitum. Mice were infected with T. 
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gondii 3 weeks after being placed on the experimental diets. All mice were inoculated 
subcutaneously (s.c) with 103 oocysts of the ME49 strain. 
In the second phase of the experiment, to study chronic infections in a susceptible 
model with the expected development of toxoplasmic encephalitis, 25 C57BL/6J mice 
were divided into 5 groups (5 mice per cage). Three weeks before inoculation, the mice 
were fed one of the five diets described above, then all 25 C57BL/6J mice were 
challenged intraperitoneally (i.p) with a higher dose of oocysts (104) of the ME49 strain. 
In the third phase of the experiment, 25 C57BL/6J mice were put under the same 
conditions as in the previous two experiments. However, because the natural route of T. 
gondii infection for humans and mice is the ingestion of food or water contaminated with 
oocysts from cat feces (Dubey et al., 1997), the C57BL/6J mice were challenged orally 
by directly pipetting oocysts (104) of the ME49 strain into the mouth. 
Weight 
In the first two phases of the study, mice were weighed upon arrival, on the day 
before they were infected with T. gondii, and throughout the course of infection. 
Histological Evaluation 
Histological studies were performed 8 weeks (chronic stage) after infection. Brains 
were removed intact from SW and C57BL/6J mice infected s.c or i.p with the ME49 
strain of T. gondii. The brains were sectioned in half (along the midline). Therefore, 
histological studies were performed on the left side of the brain, and enumerations of 
tissue cysts were done on the right side of the brain. 
The left side of the brain of each mouse was cut in half and the front half was 
placed in fixative (10% formalin). The tissue was processed and tissue sections were 
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obtained using routine histological techniques. Fixed tissue was placed in a series of 
graded ETOH baths beginning with 65%, 70%, 80%, 2 changes in 95% and 2 changes in 
absolute ETOH. Tissue remained in ETOH baths for 45 minutes each. 
After the dehydration series, the tissue was cleared using xylene (two changes in 
xylene, 45 minutes each). From the clearing agent, the tissue was then prepared for 
embedding (embedding medium was paraffin wax, two changes in wax, 45 minutes 
each). Paraffin-embedded sections were then blocked and cut into 5-|j.m sections. The 
distance between sections was 50 microns. For each tissue sample, there were 2 slides, 4 
sections per slide. Paraffin-embedded sections were then stained with hematoxylin and 
eosin, and were examined with light microscopy to evaluate the severity of tissue 
pathology. Brain lesions were based on the following 2 criteria: (1) mean size of foci 
and (2) the mean number of inflammatory foci per section. Eight sections from each 
mouse were examined, and a total of 24 sections were examined for each group. 
Cyst Number Determination 
The number of tissue cysts in the brain was determined by a technique described by 
Huskinson-Mark et al. (1991). The right side of the brain was placed in 1 ml of DPBS 
and triturated until the suspension appeared homogenous with a mortar and pestle (6 
strokes). Ten (il of Tween 20 was added to the suspension. The suspension was then 
passed 10 times through an 18-gauge needle and 20 times through a 22-gauge needle. 
Two 20-fj.l aliquots of each sample were placed on glass microscope slides that were then 
mounted with coverslips. Cysts were counted microscopically by scanning each 20-jj.I 
aliquot at a magnification of 10X. 
Statistical Evaluation 
Data were analyzed using SYSTAT. ANOVA (Analysis of Variance) was used to 
test the effect of diet on mice infected with T. gondii. Dependent variables in the 
ANOVA included weight, tissue cysts, size of foci, and the number of inflammatory foci. 
Tissue cyst number was the only variable transformed in the first phase of the study, and 
was transformed using the logio-function. The number of tissue cysts refers to the mean 
number of tissue cyst present in the brains of mice after eight weeks of infection. Weight 
refers to the percent weight change during the initial 2 weeks of infection. The size of 
foci refers to the average size of foci per section per group of mice. The number of foci 
refers to the mean number of inflammatory foci per section per group of mice. 
RESULTS 
Effect of Diet on Weight 
The weights of all mice were taken in experiment 1 and 2. The average weights of 
Swiss Webster mice prior to infection, 2 weeks post infection, and 8 weeks post infection 
with T. gondii are shown in Figure 1. Surprisingly, mice in the vitamin E plus Se group 
(vitamin E and Se in levels in excess of normal dietary intake) showed the greatest 
average weight loss during the initial 2 weeks of T. gondii infection. The percent weight 
loss for this group was more than 3 fold greater as compared to the deficient group, Se 
only group, and the vitamin E only group (see Table la; 9.57 % versus 0.65-2.97%). The 
control group (daily recommended levels of vitamin E plus Se) was the only group of 
mice that showed a percent weight gain during the initial 2 weeks of infection. However, 
there were no statistically significant differences in percent weight change among the 
different groups of Swiss Webster mice (P > 0.05), and by the eighth week of infection, 
all groups of mice had gained weight (Figure 1). 
Figure 2 shows the effect of diet on weight in T. gowdi'/'-infected C57BL/6J mice. 
Mice in the vitamin E plus Se group showed the greatest percent weight loss among all 
the groups during the initial 2-week period of infection (see Table lb; 6.49%). Percent 
weight loss in the vitamin E plus Se group was statistically significant among the other 
groups (F = 6.010, df = 20, P = 0.002). Mice on the Se only diet showed the second 
highest percent weight loss, followed by mice on the control diet (daily recommended 
levels of vitamin E plus Se), deficient diet, and vitamin E only diet (Table lb; 4.04%, 
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3.17%, 2.70% and 1.01%, respectively). Between the second and eighth week of 
infection, all C57BL/6J mice had gained weight (Figure 2). 
Effect of Diet on Tissue Cyst Number 
The effect of dietary supplementation with vitamin E and Se on number of tissue 
cysts was determined in T. gondii-infected Swiss Webster and C57BL/6J mice. Table 2a 
shows the average number of tissue cysts in the brains of Swiss Webster mice inoculated 
subcutaneously with 103 oocysts of the ME-49 strain. Counts were performed in the 
eighth week of infection. Mice in the vitamin E plus Se group (vitamin E and Se in 
levels in excess of normal dietary intake) had the greatest number of cysts in their brains. 
In contrast, mice in the deficient group (absence of vitamin E and Se from the diet) had 
the fewest number of cysts in their brains (a mean of 64 versus a mean of 339 in the 
vitamin E plus Se group). Mice on the Se only diet, vitamin E only diet, and the control 
diet had a mean number of 117, 96, and 89 tissue cysts, respectively. Overall, the 
vitamin E plus Se group showed a significant statistical difference in tissue cyst number 
among the other groups of mice (F = 3.14, df = 27, P = 0.030). 
Table 2b shows the number of tissue cysts in T. go«fi&z-infected C57BL/6J mice 
inoculated intraperitoneally with 104 oocysts. The C57BL/6J mice are more susceptible 
to the ME49 strain and are known to develop toxoplasmic encephalitis during infection. 
As in the previous experiment, mice in the supplemented groups had the highest number 
of tissue cysts present when compared to the deficient group (Table 2b). However, there 
were no statistically significant differences between the groups of mice (P > 0.05). 
In the third experiment, C57BL/6J mice were infected orally with 104 T. gondii 
oocysts. Similar to the results seen in experiment 2, the deficient group had the fewest 
number of tissue cysts present (mean of 95); (see Table 2c). Among the supplemented 
groups, mice on the Se only diet had the highest number of cysts (mean of 235), followed 
by mice on the vitamin E only diet (mean of 230), vitamin E plus Se diet (190) and the 
control diet (mean of 165). Despite these differences, there was no statistically 
significant difference between the deficient group and the supplemented groups (P > 
0.05). 
Effect of Diet on Histopathology 
At 8 weeks post infection, Swiss Webster and C57BL/6J mice were killed and 
histological analysis was performed on the left side of each brain. The histopathological 
findings for T. gondii infected Swiss Webster mice are summarized in Table 3a. Mice in 
all groups showed evidence of cellular infiltration. However, chronic inflammatory 
lesions in the brains of mice in the vitamin E plus Se group (vitamin E and Se in levels in 
excess of normal dietary intake) tended to be more severe (Figure 3). Mice in the vitamin 
E plus Se group showed more numerous and larger sites of focal inflammation in the 
parenchyma of the brain when compared to mice in the deficient and control group (daily 
recommended levels of vitamin E plus Se), (see Figure 3b, d and f). The brains from 
mice on the vitamin E plus Se diet also showed a remarkable infiltration of the meninges 
(see Figure 3e). In contrast, the number of inflammatory cells present in the meninges 
was notably less in the brains of the control mice and deficient mice (Figure 3a, and c). 
The degree of histopathology appeared to be similar in the brains of the mice in the 
vitamin E group (absence of Se) and Se group (absence of vitamin E); (data not shown). 
Mice in both supplemented groups tended to have larger inflammatory foci than mice in 
the deficient and control groups (Table 3a). Despite these observed differences in 
histopathology, there was no statistically significant difference in mean number or mean 
size of inflammatory loci in the brain parenchyma of representative mice from each 
group. 
Results of the histopathological analysis in C57BL/6J mice infected with T. gondii 
are presented in Table 3b. Similar to the previous experiment, the inflammatory response 
was much more remarkable in the vitamin E plus Se group than in the deficient group 
(Figure 4). The brains of the vitamin E plus Se group (vitamin E and Se in levels in 
excess of normal dietary intake) and control group showed an intense infiltration of 
mononuclear cells within the subarachnoid space of the meninges (Figure 4c, and e). In 
contrast, the deficient group showed far less inflammation in the parenchyma and very 
low numbers of inflammatory cells infiltrating the meninges (Figure 4a, and b). The 
overall results indicate that mice in the supplemented groups had more numerous areas of 
infiltration by mononuclear cells and larger areas of chronic focal inflammation when 
compared to mice in the deficient group (Table 3b). However, there were no statistically 
significant differences in mean size of foci ( F = 3.216, df = 9, P = 0.067) or mean 
number of inflammatory foci ( F = 1.99, df = 9, P - 0.178) among the groups of mice. 
38 
DIETS 
EHO Before infection 
• i 2 weeks P. I 
VTA 8 weeks P. I 
FIGURE 1. Effect of diet on weight in T. gondii-infected Swiss Webster mice. The 
average weight of individual mice in each group was calculated before infection with 
T. gondii, 2 weeks post-infection (P. I), and 8 weeks P. I. Data are presented as 
average weight ± standard deviation of weights of 7 mice in each group. 
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TABLE 1. Percent weight change in T. gondii-infected Swiss Webster mice (a) and 
C57BL/6J mice (b). The percent weight change per gram of average weight before 
infection with T. gondii to 2 weeks post-infection (P. I) were calculated for each group of 
mice. 
a. 
GROUPS % WEIGHT CHANGE 
Control Diet -2.01 
Deficient Diet 0.65 
Se Diet 2.27 
Vitamin E + Se Diet 9.57 
Vitamin E Diet 2.97 
b. 
GROUPS % WEIGHT CHANGE 
Control Diet 3.17 
Deficient Diet 2.70 
Se Diet 4.04 
Vitamin E + Se Diet 6.49 
Vitamin E Diet 1.01 
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DIETS 
FIGURE 2. Effect of diet on weight in T. ^ ondr/'-infected C57BL/6J mice. The 
average weight of individual mice in each group was calculated before infection with 
T. gondii, 2 weeks post-infection (P. I), and 8 weeks P. I. Data are presented as 
average weight ± standard deviation of weights of 5 mice in each group. 
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TABLE 2. Number of tissue cysts in T. go«c//7-infected Swiss Webster mice inoculated 
subcutaneously (a), C57BL/6J mice inoculated intraperitoneal^ (b), and C57BL/6J mice 
infected orally (c). Cysts number was determined at 8 weeks post-infection. Data are 
presented as the mean number of tissue cysts present in 1000 \x\ (1/2 of brain 
homogenate). 
a. 
GROUPS 
Control Diet 
Deficient Diet 
Se Diet 
Vitamin E + Se Diet 
Vitamin E Diet 
b. 
GROUPS 
Control Diet 
Deficient Diet 
Se Diet 
Vitamin E + Se Diet 
Vitamin E Diet 
NO. OF CYSTS 
89 
64 
117 
339 
96 
NO. OF CYSTS 
180 
45 
170 
155 
145 
c. 
GROUPS NO. OF CYSTS 
Control Diet 
Deficient Diet 
Se Diet 
Vitamin E + Se Diet 
Vitamin E Diet 
165 
95 
235 
190 
230 
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TABLE 3. Effect of diet on histopathology in the brain of Swiss Webster mice (a) 
and C57BL/6J mice (b) chronically infected with T. gondii. Data are presented as the 
mean size (micrometers) of foci per group of mice and the average number of 
inflammatory foci per section per group of mice. Eight sections from each mouse 
were examined. A total of 24 sections were examined for each group of mice (8 
sections from 3 different mice). 
a. 
GROUPS MEAN SIZE OF FOCI 
(Hm) 
NO. OF 
INFLAMMATORY 
FOCI PER SECTION 
Control Diet 
Deficient Diet 
Se Diet 
Vitamin E + Se Diet 
Vitamin E Diet 
139.15 
158.25 
173.47 
227.18 
171.55 
6.38 
6.13 
5.08 
8.13 
8.45 
b. 
GROUPS MEAN SIZE OF FOCI 
(Hm) 
NO. OF 
INFLAMMATORY 
FOCI PER SECTION 
Control Diet 
Deficient Diet 
Se Diet 
Vitamin E + Se Diet 
Vitamin E Diet 
175.97 
102.50 
164.95 
179.84 
167.95 
13.63 
8.39 
2.50 
8.19 
8.21 
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FIGURE 3. Histological sections from the brains of Swiss Webster mice chronically 
infected with T. gondii (ME-49) and fed the different diets. A, Brain section from a 
Swiss Webster deficient mouse (absence of vitamin E and Se from diet). Note the lack of 
inflammation in the meninges. B, Brain section from a Swiss Webster deficient mouse. 
No inflammation is apparent in the brain parenchyma. C, Brain section from a Swiss 
Webster control mouse (diet containing daily recommended levels of vitamin E and Se). 
The meninges show infiltration by large numbers of inflammatory cells (arrows). D, 
Brain section from a Swiss Webster control mouse. The brain parenchyma shows an area 
of chronic inflammation with cellular infiltration (arrow). E, Brain section from a Swiss 
Webster vitamin E plus Se mouse (diet containing vitamin E and Se in amount in excess 
of normal dietary intake). Note the widespread chronic inflammation present within the 
meninges, (arrows). F, Brain section from a Swiss Webster vitamin E plus Se mouse. 
The brain parenchyma shows a massive area of infiltration by inflammatory cells 
(arrows). Bar, 100 jam. 
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FIGURE 4. Histological sections from the brains of C57BL/6J mice chronically infected 
with T. gondii (ME-49) and fed the different diets. A, Brain section from a C57BL/6J 
deficient mouse (absence of vitamin E and Se from diet). Note the lack of inflammation 
in the meninges. B, Brain section from a C57BL/6J deficient mouse. No inflammation is 
apparent in the brain parenchyma. C, Brain section from a C57BL/6J control mouse (diet 
containing daily recommended levels of vitamin E and Se). Large numbers of 
inflammatory cells are seen infiltrating the subarachnoid space of the meninges (arrows). 
D, Brain section from a C57BL/6J control mouse. The brain parenchyma shows a large 
area of cellular infiltration (arrow). E, Brain section from a C57BL/6J vitamin E plus Se 
mouse (diet containing vitamin E and Se in amount in excess of normal dietary intake). 
Note regions of cellular infiltration within the meninges (arrows). F, Brain section from a 
C57BL/6J vitamin E plus Se mouse. The brain parenchyma shows several areas of 
infiltration by inflammatory cells (arrows). Bar, 100 i^m. 
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DISCUSSION 
In the present study the effects of dietary supplementation with vitamin E and Se 
during murine infection with T. gondii were investigated. The severity of infection was 
evaluated by monitoring weight, tissue cyst numbers, and the extent of tissue pathology. 
Vitamin E and Se supplementation has been associated with an enhancement of the 
immune response, increasing resistance to a variety of pathogenic infections and tumors 
in animal models and humans (Wang et al., 1994a). Previous studies in our laboratory 
have shown that supplementation of mice with vitamin E and Se does provide benefit 
against the intracellular parasite, Trypanosoma cruzi (Davis et al., 1998 and Hou, 1997). 
Dietary supplementation with vitamin E and Se in mice infected with T. cruzi resulted in 
increased longevity, decreased parasitemias and reduced weight loss during infection. 
The beneficial effects of vitamin E and Se may be attributable in part to the well known 
antioxidant properties of both of these nutrients. Selenium is an essential dietary 
micronutrient required for normal growth and development, and functions as an 
antioxidant at the cellular level. Selenium is necessary for the synthesis and activity of 
the peroxide-destroying enzyme glutathione peroxidase. Glutathione peroxidase 
functions as a cellular protector against oxidative damage by catalyzing the reduction of 
hydrogen peroxide and organic hydroperoxides (Madhavi et al., 1995). Vitamin E is a 
lipid-soluble antioxidant that protects polyunsaturated fatty acids (PUFAs) and other 
components of cell and organelle membranes from oxidation by reactive free radicals 
(Dutta-Roy et al., 1994). Several studies have indicated that both antioxidants show a 
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synergistic effect in depressing lipid peroxide formation in vivo and in vitro (Madhavi et 
al., 1995). In addition, vitamin E and Se have been shown to have immunostimulatory 
effects in a variety of species when administered in quantities in excess of established 
dietary requirements (Sheffy and Schultz, 1979). Supplementation with vitamin E and Se 
has been shown to improve the function of neutrophils, and to increase antibody 
responses of animals (chickens, pigs, and horses) (Finch and Turner, 1996). However, 
the results of the present study demonstrate that vitamin E and Se supplementation was 
not beneficial during murine infection with the protozoan parasite, T. gondii. Increased 
dietary vitamin E and Se supplementation resulted in increased cyst number, tissue 
pathology, and weight loss during infection. In contrast, mice fed the deficient diet 
(absence of vitamin E and Se) showed the lowest number of tissue cysts and very little 
evidence of tissue pathology during chronic infection. 
Weight was monitored throughout the study as an indicator of severity of disease. 
Although there were no statistically significant differences in percent weight loss in the 
Swiss Webster mice, the vitamin E plus Se group (vitamin E plus Se in levels in excess of 
normal dietary intake) showed the greatest percent weight change during the first two 
weeks of infection. Similar results were obtained in the second phase of the study. 
C57BL/6J mice on the vitamin E plus Se diet also had the highest percent weight loss 
during the initial 2 weeks of infection (P < 0.005). Percent weight loss over the first two 
weeks of infection is a good indicator of disease severity because this is the time when 
mice are showing other clinical signs of acute illness, such as ruffled coat, decreased 
activity, and decreased appetite. Two weeks after infection, mice pass the acute phase 
and go into the chronic phase of the disease which is characterized by the formation of 
tissue cysts in the brain. In the present study, increased weight loss during the acute 
phase of infection was correlated with an increased tissue cyst burden in the chronic stage 
of infection. In the first experiment, the Swiss Webster mice in the vitamin E plus Se 
group had the greatest number of tissue cysts present (P < 0.05). In the second 
experiment, the C57BL/6J in the vitamin E plus Se group and the Se only group suffered 
the highest percent weight loss, and this too was correlated with a high tissue cyst burden 
in their brains. The C57BL/6J supplemented groups had high tissue cyst numbers 
compared to the C57BL/6J deficient group (Table 2). This trend was similar in the third 
phase of the study, in which C57BL/6J mice were inoculated orally (natural route) using 
oocysts as the inoculum. Mice in the supplemented groups had the greatest number of 
tissue cysts in their brains compared to the deficient group (Table 2). These results 
strongly suggest that dietary supplementation with vitamin E and Se in both mouse 
models of T. gondii infection is actually detrimental to the host, whereas a pro-oxidant 
diet (one totally lacking in vitamin E and Se) appears to be beneficial. 
The number of cysts in the brain appears to be one of the major factors that 
determine development of toxoplasmic encephalitis (Suzuki et al., 1993). Therefore, it 
would be expected that mice in the supplemented groups would be more likely to exhibit 
toxoplasmic encephalitis, since they formed a greater number of tissue cysts than mice in 
the non-supplemented groups. This prediction is consistent with the histological 
evaluation of inflammatory responses in the brains of mice chronically infected with T. 
gondii. Eight weeks after T. gondii infection, mice in the Swiss Webster vitamin E plus 
Se group showed evidence of severe meningo-encephalitis with an extensive infiltration 
by large numbers of inflammatory cells within the subarachnoid space of the meninges. 
Swiss Webster mice in the vitamin E group, Se group, and control group all had apparent 
inflammation; however inflammatory lesions in the vitamin E plus Se group were 
remarkably more severe (particularly within the meninges) (Figure 3e). In the second 
phase of the histological study, C57BL/6I mice in the supplemented groups also 
exhibited severe menigo-encephalitis (Figure 4). The brain parenchyma of mice in the 
C57BL/6J vitamin E group and Se group also showed several areas of chronic focal 
inflammation populated by very large numbers of mononuclear cells (Table 3). 
Inflammatory cells also were noted within the subarachnoid space of the meninges of the 
brains. Despite the obvious clinical differences observed between the groups of Swiss 
Webster and C57BL/6J mice, there were no statistically significant differences in brain 
lesion size, or the number of foci. This result may be attributable to the small sample size 
used in the histological analysis and the large variance between individual mice within 
groups. 
In both Swiss Webster and C57BL/6J mice, the lowest degree of tissue pathology 
and cyst number was exhibited by mice in the deficient group (absence of vitamin E and 
Se). In striking contrast, results of a variety of studies have shown that supplementation 
with antioxidants can provide a beneficial effect during microbial infection (Davis et al., 
1998, Grimble, 1997, and Hou, 1997). However, similar results have been reported in 
other studies. Selenium deficiency was shown to increase survival of rats infected with 
Salmonella typhimurium and mice infected with Plasmodium bergeii, Listeria 
monocytogenes, or Pseudorabies virus (Boyne and Arthur, 1986). In a study involving 
mice infected with the helminth parasite, Schistosoma mansoni, it was shown that a diet 
deficient in vitamin E and Se impaired the development of S. mansoni by decreasing the 
number of adult worms and liver surface nodule scores (Levander et al., 1995). Levander 
et al. (1995) also have reviewed the effects of vitamin E supplementation during malaria. 
Malaria is a disease caused by an intraerythrocytic parasite belonging to the genus 
Plasmodium. Plasmodium lives in an oxygen rich environment (the red blood cell) and is 
known to be susceptible to the negative effects of oxidative stress. When mice were fed 
dietary fish oil (a known tocopherol antagonist), it partially protected the mice against 
murine cerebral malaria. However, that protection could be made virtually complete 
when the fish oil was fed to vitamin E-deficient mice. In addition, vitamin E deficiency 
markedly improved the survival of infected mice fed on fish oil, whereas all the mice 
died in the vitamin E supplemented group (Levander et al., 1995). Levander et al. (1995) 
showed that a variety of fish oils and fish-oil concentrates fed in the diet exerted this 
antimalarial activity in vitamin E-deficient mice. A plant oil containing n-3 fatty acids 
(linseed oil) also had this antimalarial property in vitamin-E deficient mice as did ground 
flaxseed and chemically purified ethyl linolenate (Levander et al., 1995). The 
biochemical mechanism by which fish oils exert their beneficial effect against malaria is 
not certain since these oils are known to have a wide-ranging impact on several aspects of 
metabolism. Nonetheless, the most reasonable and straightforward explanation for this 
antimalarial property of fish oil seems to be its ability to exert pro-oxidant stress on the 
parasite (Levander et al., 1995). The malarial parasite is highly sensitive to oxidative 
stress and a pro-oxidant diet should promote the accumulation of oxygen free radicals 
(i.e., superoxide anion, singlet oxygen, hydroxyl radicals, and hydrogen peroxide), 
thereby increasing oxidative stress and causing the destruction of the malarial parasite. 
Dietary induced oxidative stress provided protection against the later sequelae of malarial 
infection (i.e., anemia) by suppressing parasite growth, but also protected against the 
early manifestations of the disease (central nervous system consequences; headaches, 
convulsions and coma) (Levander et al., 1995). Thus, dietary deprivation of vitamin E in 
this experimental model was beneficial to the host in its defense against the malarial 
parasite. In a similar study of mice infected with Babesia rodhani (Levander et al., 
1995), it was demonstrated that mice fed fish oil in a low vitamin E diet were protected 
from the pathological effects of B. rodhani. Similarly, young chicks maintained on 
flaxseed oil (pro-oxidant diet) exhibited decreased severity of caecal lesions when 
infected with the coccidial parasite, Eimeria tenella (Levander et al., 1995). Gamain et 
al. (1995) have studied the effects of selenium supplementation during the in vitro 
cultivation of Plasmodium. They observed an increase in the growth of Plasmodium 
falciparum (human malaria) and Plasmodium yoeli (murine malaria) in cultures 
supplemented with sodium selenite. The authors concluded from the study that the 
malarial parasite might possess an endogenous Se-dependent enzyme, such as glutathione 
peroxidase (Se-Gpx), to protect itself from the deleterious effects of oxidative stress 
(Gamain et al., 1995). Glutathione peroxidase is a key enzyme involved in the reduction 
of several organic hydroperoxides (ROOH) and hydrogen peroxide (H2O2). Selenium is 
a metal cofactor for Se-GPx, and Se must be incorporated in order for this enzyme to be 
expressed. Based upon the results of these studies, it was proposed that Plasmodium 
might be using the antioxidants vitamin E and Se for its own benefit, for protection from 
oxidative stress, as well as promotion of parasitic growth. Babesia, Eimeria, Plasmodium 
and Toxoplasma all belong to the phylum Apicomplexa, and these organisms may use a 
common mechanism in their defense against oxidative damage. 
The present study strongly suggests that dietary supplementation with vitamin E 
and Se does increase the severity of murine infection with T. gondii as shown by an 
increase in cyst numbers, tissue pathology and percent weight loss, when compared to 
mice maintained on a pro-oxidant diet totally lacking in vitamin E and Se. Furthermore, 
Swiss Webster mice are not noted for developing toxoplasmic encephalitis during T. 
gondii infection, whereas C57BL/6J mice are regarded as a more susceptible model of 
infection and also serve as a common model for toxoplasmic encephalitis. However, the 
results of the present study indicate that Swiss Webster mice receiving a lower inoculum 
actually exhibited more severe pathology than C57BL/6J mice. Overall, Swiss Webster 
mice on the vitamin E plus Se diet had the highest number of tissue cysts present in their 
brains and the most severe meningo-encephalitis. The number of cysts in the brain 
appears to be one of the primary factors that determine development of toxoplasmic 
encephalitis (Suzuki et al., 1993). This result suggests that Swiss Webster mice (who do 
not normally develop toxoplasmic encephalitis) can be rendered susceptible to 
toxoplasmic encephalitis if maintained on a diet containing high levels of the antioxidants 
vitamin E and Se. 
The results of this study may have important implications for patients infected with 
HIV and who also are infected with T. gondii. Most cases of toxoplasmosis in HIV 
patients occur during the late stage of AIDS (Harbige, 1996). Nutrition in relation to 
HIV/AIDS has attracted the attention of scientists and people with HIV/AIDS for many 
reasons (Harbige, 1996). Vitamin and mineral deficiencies are common among both 
symptomatic and asymptomatic HIV-infected individuals, and nutritional 
supplementation in an attempt to correct these deficiencies is common (Spach et al, 
1996). In addition, megadoses and multiple combinations of vitamins and minerals have 
been used commonly in an attempt to interrupt or delay progression of disease (Spach et 
al., 1996). However, in the case of an AIDS patient, suffering from toxoplasmosis, 
would these vitamin and mineral supplements still be beneficial? Toxoplasmic 
encephalitis (TE) remains a major cause of morbidity and mortality in patients with AIDS 
(Suzuki et al., 1993). If supplementation with antioxidants favors the growth of T. gondii 
rather than providing benefit to the host, then dietary supplementation with certain 
vitamins and minerals with antioxidant properties could actually exacerbate the infection 
and lead to serious complications in immunocompromised individuals. Further studies 
must be performed to fully evaluate the impact of dietary supplementation with 
antioxidants during T. gondii infection in mice as well as in humans. 
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